The Cigna Group
NYQ: CILive Quote
About The Cigna Group
Healthcare
Healthcare Plans
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
📊 Fundamental Analysis
The Cigna Group demonstrates a profit margin of 2.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported 10.4% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 15.1%, which suggests room for improvement in capital utilization.
At a current price of $271.25, CI currently sits at the 29th percentile of its 52-week range (Range: $239.51 - $350.00).
💰 Valuation Insight
CI trades at a 51.1% discount (PE: 12.22), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
⚠️
Revenue Growth
Moderate
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$78.04B
Trailing P/E
12.22
Forward P/E
8.11
Beta (5Y)
0.27
52W High
$350.00
52W Low
$239.51
Avg Volume
1.74M
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App